CorMedix (CRMD) Non-Current Assets (2010 - 2025)

CorMedix has disclosed Non-Current Assets across 15 years of filings, most recently posting $459.1 million for Q4 2025.

• Non-Current Assets for Q4 2025 came in at $459.1 million, up 10649.03% year-over-year; the trailing twelve-month figure through Dec 2025 was $959.7 million (up 5275.36% YoY), and the FY2025 annual result was $459.1 million, up 10649.03% from the prior year.
• Non-Current Assets came in at $459.1 million for Q4 2025 at CorMedix, down from $491.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $491.3 million in Q3 2025 to a low of $1.2 million in Q2 2021.
• The 5-year median for Non-Current Assets is $2.5 million (2021), against an average of $50.2 million.
• Across the five-year window, Non-Current Assets dropped 1.9% in 2023 and jumped 10986.07% in 2025, its largest moves.
• CorMedix's Non-Current Assets stood at $2.5 million in 2021, then grew by 0.42% to $2.5 million in 2022, then advanced by 4.92% to $2.6 million in 2023, then surged by 63.67% to $4.3 million in 2024, then surged by 10649.03% to $459.1 million in 2025.
• The last three Non-Current Assets figures came in at $459.1 million (Q4 2025), $491.3 million (Q3 2025), and $4.5 million (Q2 2025), per Business Quant data.